Assignee
SILVERBACK THERAPEUTICS INC
US·6 granted patents·17 pending applications·32 citations·filing 2018–2021
Top patents by PatentIndex Score
23 records- 0194US11179473B2Nectin-4 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Nov 23, 2021·7 cites·30 claims
- 0294US10428045B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2019·7 cites·39 claims
- 0393US10519131B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·13 claims
- 0493US10442790B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Granted Oct 15, 2019·5 cites·41 claims
- 0590US10239862B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Granted Mar 26, 2019·7 cites·21 claims
- 0670US2020031798A1Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0765US11541126B1Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·30 claims
- 0863US2023062712A1Anti-asgr1 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0953US2022048895A1Substituted benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1053US2022362396A1Amino-pyrazinecarboxamide compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1150US2021154188A1Alk5 inhibitors, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1250US2020113912A1Methods and Compositions for the Treatment of Disease with Immune Stimulatory ConjugatesSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1350US2022169660A1Cyclic amino-pyrazinecarboxamide compounds and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1450US2021130473A1TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOFSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1550US2021154317A1Compositions and methods for the treatment of viral infectionsSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1650US2021139477A1Alk5 inhibitors, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1749US2022249685A1Anti-mesothelin antibodies and immunoconjugates thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1849US2021077632A1Formulations of Benzazepine Conjugates and Uses ThereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1949US2021115109A1Conjugates and methods of use thereof for selective delivery of immune-modulatory agentsSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2046US2020199242A1Construct-peptide compositions and methods of use thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2146US2022323596A1Antibody conjugates of toll-like receptor agonistsSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2243US2020199247A1Antibody conjugates of immune-modulatory compounds and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2341US2019336615A1Tumor targeting conjugates and methods of use thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SILVERBACK THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →